瑞科生物-B大跌5.27% 近日取得重组带状疱疹疫苗《药品生产许可证》增项

港美通11-17

11月17日14:21，瑞科生物-B(02179)股价大幅下跌5.27%。该股报5.750港元，最高报5.750港元，最低报5.750港元，成交量0.10万股，成交额0.58万港元。消息面上，瑞科生物近日发布公告称，公司已获得江苏省药品监督管理局颁发的《药品生产许可证》增项批准，新增重组带状疱疹疫苗（CHO细胞）及相关佐剂成分的生产范围（“本次增项”）。本次增项标志着本集团在预防用生物制品领域的...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2584063836?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-11-17 14:36","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2584063836","market":"hk","top_or_hot":-1,"title":"瑞科生物-B大跌5.27% 近日取得重组带状疱疹疫苗《药品生产许可证》增项","media":"港美通","content":"<div>\n<p>11月17日14:21，瑞科生物-B(02179)股价大幅下跌5.27%。该股报5.750港元，最高报5.750港元，最低报5.750港元，成交量0.10万股，成交额0.58万港元。消息面上，瑞科生物近日发布公告称，公司已获得江苏省药品监督管理局颁发的《药品生产许可证》增项批准，新增重组带状疱疹疫苗（CHO细胞）及相关佐剂成分的生产范围（“本次增项”）。本次增项标志着本集团在预防用生物制品领域的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117144027a6fea606&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>瑞科生物-B大跌5.27% 近日取得重组带状疱疹疫苗《药品生产许可证》增项</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n瑞科生物-B大跌5.27% 近日取得重组带状疱疹疫苗《药品生产许可证》增项\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-17 14:36 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117144027a6fea606&s=b><strong>港美通</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>11月17日14:21，瑞科生物-B(02179)股价大幅下跌5.27%。该股报5.750港元，最高报5.750港元，最低报5.750港元，成交量0.10万股，成交额0.58万港元。消息面上，瑞科生物近日发布公告称，公司已获得江苏省药品监督管理局颁发的《药品生产许可证》增项批准，新增重组带状疱疹疫苗（CHO细胞）及相关佐剂成分的生产范围（“本次增项”）。本次增项标志着本集团在预防用生物制品领域的...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117144027a6fea606&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117144027a6fea606&s=b","article_id":"2584063836","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117144027a6fea606&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2584063836","pubTimestamp":1763361413,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"11月17日14:21，瑞科生物-B股价大幅下跌5.27%。消息面上，瑞科生物近日发布公告称，公司已获得江苏省药品监督管理局颁发的《药品生产许可证》增项批准，新增重组带状疱疹疫苗及相关佐剂成分的生产范围。本次增项标志着本集团在预防用生物制品领域的研发与生产能力实现进一步拓展，为后续药品上市注册奠定坚实基础。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1161":"生物科技","02179":"瑞科生物-B"},"translate_title":"Ruike Bio-B fell 5.27% and recently obtained an additional item to the recombinant herpes zoster vaccine \"Drug Production License\"","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02179":1.5},"content_text":"11月17日14:21，瑞科生物-B(02179)股价大幅下跌5.27%。该股报5.750港元，最高报5.750港元，最低报5.750港元，成交量0.10万股，成交额0.58万港元。消息面上，瑞科生物近日发布公告称，公司已获得江苏省药品监督管理局颁发的《药品生产许可证》增项批准，新增重组带状疱疹疫苗（CHO细胞）及相关佐剂成分的生产范围（“本次增项”）。本次增项标志着本集团在预防用生物制品领域的研发与生产能力实现进一步拓展，为后续药品上市注册奠定坚实基础。江苏瑞科生物技术股份有限公司是一家以自主研发技术为核心驱动力的创新型疫苗公司，致力于打造覆盖研发、生产及商业化的创新型疫苗全价值链。司已建立由10余款高度差异化组成的高价值创新型疫苗组合,覆盖宫颈癌、带状疱疹、新冠肺炎、流感等具有重大负担的疾病领域。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2584063836","isCrawlerRequest":true}